Reactive oxygen metabolite action in experimental, stress model of gastric mucosa damage;Przemiany reaktywnych form tlenu w doświadczalnym, stresowym modelu uszkodzeń błony śluzowej żoła̧dka

Gastroenterologia Polska

Volumn 17, Issue 3, 2010, Pages 234-243

  Kwiecień, Sławomir ^a   Pawlik, Michał W ^a   Brzozowski, Tomasz ^a   Pawlik, Wiesław W ^a   Konturek, Stanisław J ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Gastric mucosa; Glutathione; Lipid peroxidation; Reactive oxygen species; Superoxide dismutase

Indexed keywords

4 HYDROXYNONENAL; GLUTATHIONE; HYDROGEN PEROXIDE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

CHEMICAL REACTION; ENZYME ACTIVITY; HUMAN; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; REVIEW; STOMACH MUCOSA; STOMACH MUCOSA INJURY;

EID: 77956401871     PISSN: 12329886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (127)

1. Brzozowski T.: Gastroprotekcja in vivo i in vitro. Pat. Pol., 1992, 43, 1-19.
2. Kwiecień S., Konturek S.J.: Gastric analysis with fractional test meals (ethanol, caffeine and peptone meal), augmented histamine or pentagastrin tests and gastric pH recording. J. Physiol. Pharmacol., 2003, 54, suppl. 3, 69-82.
3. Kwiecień S., Brzozowski T., Konturek P.C., Konturek S.J., Pawlik M., Pajdo R., Drozdowicz D., Ptak A., Hahn E.G.: Effect of central and peripheral actions of histamine and its metabolite N-alpha methyl histamine on gastric secretion and acute gastric lesions. J. Physiol. Pharmacol., 2001, 52, 625-638.
4. Konturek S.J.: Fizjologia układu trawiennego. PZWL, Warszawa, 1985.
5. Konturek P.C., Brzozowski T., Burnat G., Kwiecień S., Pawlik T., Hahn E.G, Konturek S.J.: Role of brain-gut axis in healing of gastric ulcers. J. Physiol. Pharmacol., 2004, 55, 179-192.
6. Konturek J.W.: Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori. J. Physiol. Pharmacol., 1994, 45, suppl. 1, 4-59.
7. Konturek P.C.: Physiological, immunohistochemical and molecular aspects of gastric adaptation to stress, aspirin and to H. pylori-derived gastrotoxins. J. Physiol. Pharmacol., 1997, 48, 3-42.
8. Brzozowski T., Drozdowicz D., Szlachcic A., Pytko-Polończyk J., Majka J., Konturek S.J.: Role of nitric oxide and prostaglandins in gastroprotection induced by capsaicin and papaverine. Digestion ,1993, 54, 24-31.
9. Śliwowski Z., Brzozowski T., Gołembiowska K., Drozdowicz D., Pajdo R., Kwiecień S., Konturek S.J.: Rola układu adrenergicznego w gastroprotekcyjnym działaniu nabłonkowego czynnika wzrostu i prostaglandyn. Gastroenterol. Pol., 1999, 6, 93-104.
10. Konturek P.C., Brzozowski T., Konturek S.J., Taut A., Kwiecień S., Pajdo R., Śliwowski Z., Hahn E.G.: Bacterial lipopolysaccharide protects gastric mucosa against acute injury in rats by activation of genes for cyclooxygenases and endogenous prostaglandins. Digestion, 1998, 59, 284-297.
11. Brzozowski T., Konturek P.C., Pierzchalski P., Konturek S.J., Drozdowicz D., Kwiecień S., Pajdo R., Hahn E.G.: Role of nitric oxide (NO) and sensory nerves in gastroprotective action of leptin and cholecystokinin (CCK) in the rat gastric mucosa. [w:] Neurogastroenterology. From the basics to the clinics. (red.) H.J. Krammer, M.V. Singer. Kluwer Academic Publishers, Dordrecht, 1999, 731-737.
12. Konturek S.J., Konturek P.C.: Role of nitric oxide in digestive system. Digestion, 1995, 56, 1-13.
13. McNaughton W.K., Cirino G., Wallace J.L.: Endothelium-derived relaxing factor (nitric oxide) has protective action in the stomach. Life Sci., 1989, 45, 1869-1876.
14. Brzozowski T., Konturek S.J., Brzozowska I., Śliwowski Z., Drozdowicz D., Zaczek M.: Role of L-arginine, a substrate for nitric oxide-synthase, in gastroprotection and ulcer healing. Gastroenterol. Pol., 1997, 4, 339-349.
15. Guzik T.J., Korbut R., Adamek-Guzik T.: Nitric oxide and superoxide in inflammation and immune regulation. J. Physiol. Pharmacol., 2003, 54, 469-487.
16. Ignarro L.J.: Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J. Physiol. Pharmacol., 2002, 53, 503-514.
17. Katsuki S., Arnold W., Mittal C., Murad F.: Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J. Cyclic Nucleotide Res., 1977, 3, 23-35.
18. Wybrańska I., Miszczuk-Jamska B., Baczyńska E., Goldsztajn P., Sowa G., Przewłocki R., Gryglewski R., Dembińska-Kieć A.: Influence of SIN-1 and sodium nitroprusside (NANP) on OX-LDL metabolism in macrophages. J. Physiol. Pharmacol., 1994, 45, 387-397.
19. Dembińska-Kieć A., Żmuda A., Marcinkiewicz J., Sinzinger H., Gryglewski R.J.: Influence of NO-donor (SIN-1) on functions of inflammatory cells. Agents Actions, 1991, 1/2, 37-40.
20. Styś T., Styś A., Paczwa P., Szczepańska-Sadowska E., Lipkowski A.W.: Decreased hypotensive responsiveness to nitric oxide donor S-nitroso-N-acetyl DL-penicillamine (SNAP) in spontaneously hypertensive (SHR) rats. J. Physiol. Pharmacol., 1998, 49, 37-49.
21. Askew S.C., Butler A.R., Flitney F.W., Kemp G.D., Megson I.L.: Chemical mechanisms underlying the vasodilator and platelet anti-aggregating properties of S-nitroso-N-acetyl- DL-penicillamine and S-nitrosoglutatathione. Bioorg. Med. Chem., 1995, 3, 1-9.
22. Shaffer J.E., Han B.J., Chern W.H., Lee F.W.: Lack of tolerance to a 24-hour infusion of S-nitroso-N-acetylpenicillamine (SNAP) in conscious rabbits. J. Pharmacol. Exp. Ther., 1992, 260, 283-292.
23. Kwiecień S., Brzozowski T., Konturek P.Ch, Konturek S.J.: The role of reactive oxygen species in action of nitric oxide-donors on stress-induced gastric mucosal lesions. J. Physiol. Pharmacol., 2002, 53, 761-773.
24. Axelsson K.L., Andersson R.G.: Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover. Eur. J. Pharmacol., 1983, 88, 71-79.
25. Brzozowski T., Konturek P.Ch., Konturek S.J., Śliwowski Z., Drozdowicz D., Kwiecień S., Pajdo R., Ptak A., Pawlik M., Hahn E.G.: Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs. Digest. Liver Dis., 2000, 32, 583-594.
26. Brzozowska I., Targosz A., Śliwowski Z., Kwiecień S., Drozdowicz D., Pajdo R., Konturek P.C., Brzozowski T., Pawlik M., Konturek S.J., Pawlik W.W., Hahn E.G: Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor. J. Physiol. Pharmacol., 2004, 55, 773-790.
27. Konturek P.C., Brzozowski T., Ptak A., Kania J., Kwiecień S., Hahn E.G., Konturek S.J.: Nitric oxide releasing aspirin protects the gastric mucosa against stress and promotes healing of stress-induced gastric mucosal damage: role of heat shock protein 70. Digestion, 2002, 66, 160-172.
28. Stajkowska I., Łuczkowska M., Żaba R.: Pentoxyfilina i buflomedil - możliwość zastosowania w dermatologii. Przew. Lek., 2003, 9, 42-49.
29. Kwiecień S., Brzozowski T., Konturek P.C, Pawlik M.W., Pawlik W.W., Kwiecień N., Konturek S.J.: Gastroprotection by pentoxyfilline against stress-induced gastric damage. Role of lipid peroxidation, antioxidizing enzymes and proinflammatory cytokines. J. Physiol. Pharmacol., 2004, 55, 337-355.
30. Kwiecień S., Brzozowski T., Konturek S.J.: Znaczenie aldehydowych produktów peroksydacji lipidów w doświadczalnych uszkodzeniach błony śluzowej żoła̧dka indukowanych przez aspirynȩ, stres i ischemiȩ z nastȩpowa̧ reperfuzja̧. Gastroenterol. Pol., 2002, 9, 273-280.
31. Ma J.J., Hou D.Q., Zhang Q.B., Korsten M.A.: Reversal of the gastric effects of nicotine by nitric oxide donor treatment. Digestion, 2001, 63, 102-107.
32. Brzozowski T., Konturek P.C., Konturek S.J., Kwiecień S., Pajdo R., Brzozowska I., Hahn E.G.: Involvement of endogenous cholecystokinin and somatostatin in gastroprotection, induced by intraduodenal fat. J. Clin. Gastroenterol., 1998, 27, suppl. 1, 125-137.
33. Brzozowski T., Ptak A., Kwiecień S., Pajdo R., Drozdowicz D., Pawlik M, Konturek S.J., Pawlik W.W.: Importance of nitric oxide (NO) and adenosine in the mechanism of gastric preconditioning induced by short ischemia. Ann. Acad. Med. Bialos., 2003, 48, 42-47.
34. Brzozowski T., Konturek P.C., Konturek S.J., Kwiecień S., Pajdo R., Karczewska E., Stachura J., Hahn E.G.: Water extracts of Helicobacter pylori delay healing of chronic gastric ulcers in rats: role of cytokines and gastrin-somatostatin link. Digestion, 1999, 60, 22-33.
35. Kwiecień S., Brzozowski T., Śliwowski Z., Konturek S.J.: Infekcja Helicobacter pylori w doświadczalnym modelu uszkodzeń błony śluzowej żoła̧dka powstałych w wyniku ischemii i reperfuzji. Gastroenterol. Pol., 2001, 8, 111-125.
36. Konturek S.J., Brzozowski T., Pajdo R., Konturek P.Ch., Kwiecień S., Śliwowski Z., Pawlik M, Ptak A., Drozdowicz D., Hahn E.G.: Gastric preconditioning induced by short ischemia: the role of prostaglandins, nitric oxide and adenosine. Med. Sci. Monit., 2001, 7, 610-621.
37. Bilski J., Konturek S.J., Bielański W.: Role of endogenous nitric oxide in the control of exocrine and endocrine pancreatic secretion. J. Physiol. Pharmacol., 1995, 46, 447-462.
38. Ishii K.B., Chang B., Kerwin J.F., Huang Z.J., Murad F.: N-nitro-L-arginine a potent inhibitor of endothelium-derived relaxing factor formation. Eur. J. Pharmacol., 1990, 176, 219-223.
39. Konturek S.J., Brzozowski T., Majka J., Pytko-Polończyk J., Stachura J.: Inhibition of nitric oxide synthase delays the healing of chronic gastric ulcers. Eur. J. Pharmacol., 1993, 239, 215-217.
40. Palmer R.M.J., Rees D.D., Ashton D.S., Moncada S.: L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun., 1988, 153, 1251-1259.
41. Brzozowski T., Konturek S.J., Drozdowicz D., Dembiński A., Stachura J., Pytko-Polończyk J.: Healing of chronic gastric ulceration by L-arginine. Role of endogenous prostaglandins, nitric oxide and polyamines. Digestion, 1995, 56, 463-471.
42. Brzozowski T., Konturek P.Ch., Konturek S.J., Pajdo R., Drozdowicz D., Kwiecień S., Hahn E.G.: Acceleration of ulcer healing by cholecystokinin (CCK): role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves. Regul. Pept., 1999, 82, 19-33.
43. Brzozowski T., Konturek P.C., Moran A.P., Pajdo R., Kwiecień S., Konturek S.J., Śliwowski Z., Drozdowicz D., Pawlik W.W., Hahn E.G.: Involvement of capsaicin-sensitive afferent nerves and cholecystokinin 2/gastrin receptors in gastroprotection and adaptation of gastric mucosa to Helicobacter pylori-lipopolysaccharide. J. Pharmacol. Exp. Ther., 2004, 310, 116-125.
44. Brzozowski T., Konturek P.C., Konturek S.J., Pajdo R., Kwiecie? S., Pawlik M., Drozdowicz D., Śliwowski Z., Pawlik W.W.: Ischemic preconditioning of remote organs attenuates gastric ischemia-reperfusion injury through involvement of prostaglandins and sensory nerves. Eur. J. Pharmacol., 2004, 499, 201-213.
45. Brzozowski T., Konturek P.C., Śliwowski Z., Drozdowicz D., Hahn E.G., Konturek S.J.: Importance of nitric oxide and capsaicin-sensitive afferent nerves in healing of stress lesions induced by epidermal growth factor. J. Clin. Gastroenterol., 1997, 25, suppl.1, S28-S38.
46. Pawlik W.W., Thor P., Sendur R., Biernat J., Kozio? R., Wa̧sowicz P.: Myoelectric bowel activity in ischemia/reperfusion damage. Role of sensory nerves. J. Physiol. Pharmacol., 1998, 49, 543-551.
47. Pawlik W.W., Obuchowicz R., Biernat J., Sendur R., Jaworek J.: Role of calcitonin gene related peptide in the modulation of intestinal circulatory, metabolic and myoelectric activity during ischemia/reperfusion. J. Physiol. Pharmacol., 2000, 51, 933-942.
48. Kwiecień S., Konturek S.J.: Choroby czynnościowe przewodu pokarmowego. [w:] Gastroenterologia w praktyce. (red.). A. Gabryelewicz. PZWL, Warszawa 2002, 101-117.
49. Pawlik W.W., Obuchowicz R., Pawlik M.W., Sendur R., Biernat J., Brzozowski T., Konturek S.J.: Histamine H3 receptors modulate reactive hyperemia in rat gut. J. Physiol. Pharmacol., 2004, 55, 651-661.
50. Pawlik M.W., Brzozowski T., Śliwowski Z., Konturek S.J.: Effect of epidermal growth factor (EGF) and polyamines on the healing of gastric mucosal lesions induced by ischemiare-perfusion. Gastroenterol. Pol., 2001, 8, 307-318.
51. Pawlik M., Ptak A., Pajdo R., Konturek P.C., Brzozowski T., Konturek S.J.: Sensory nerves and calcitonin gene related peptide in the effect of ischemic preconditioning on acute and chronic gastric lesions induced by ischemia-reperfusion. J. Physiol. Pharmacol., 2001, 52, 569-581.
52. Biernat J., Pawlik W.W., Sendur R., Dembiński A., Brzozowski T., Konturek S.J.: Role of afferent nerves and sensory peptides in the mediation of hepatic artery buffer response. J. Physiol. Pharmacol., 2005, 56, 133-145.
53. Sterini C., Reeve J.R., Brecha N.: Distribution and characterization of calcitonin gene related peptide immunoreactivity in the digestive system of normal and capsaicin-treated rats. Gastroenterology, 1987, 93, 852-862.
54. Brzozowski T., Konturek S.J., Śliwowski Z., Pytko-Polończyk J., Szlachcic A., Drozdowicz D.: Role of capsaicin-sensitive sensory nerves in gastroprotection against acid-independent and acid-dependent ulcerogenesis. Digestion, 1996, 57, 424-432.
55. Kwiecień S., Brzozowski T., Konturek P.C., Pawlik M.W., Pawlik W.W., Kwiecień N., Konturek S.J.: The role of reactive oxygen species and capsaicin-sensitive sensory nerves in the pathomechanism of gastric ulcers induced by stress. J. Physiol. Pharmacol., 2003, 54, 423-437.
56. Brzozowska I., Konturek P.C., Brzozowski T., Konturek S.J., Kwiecień S., Pajdo R., Drozdowicz D., Pawlik M, Ptak A., Hahn E.G.: Role of prostaglandins, nitric oxide, sensory nerves and gastrin in acceleration of ulcer healing by melatonin and its precursor, L-tryptophan. J. Pineal. Res., 2002, 32, 149-162.
57. Pajdo R., Brzozowski T., Konturek P.C., Kwiecień S., Konturek S.J., Śliwowski Z., Pawlik M., Ptak A., Drozdowicz D., Hahn E.G.: Ischemic preconditioning, the most effective gastroprotective intervention: involvement of prostaglandins, nitric oxide, adenosine and sensory nerves. Eur. J. Pharmacol., 2001, 427, 263-276.
58. Konturek P.C., Brzozowski T., Konturek S.J., Kwiecień S., Dembiński A., Hahn E.G.: Influence of bacterial lipopolysaccharide on healing of chronic experimental ulcer in rat. Scand. J. Gastroenterol., 2001, 12, 1239-1247.
59. Konturek P.C., Brzozowski T., Pierzchalski P., Kwiecień S., Pajdo R., Hahn E.G.: Activation of genes for spasmolytic peptide, transforming growth factor alpha and for cyclooxygenase (COX)-1 and COX-2 during gastric adaptation to aspirin damage in rats. Aliment. Pharmacol. Ther., 1998, 12, 767-777.
60. Brzozowski T., Kwiecień S., Konturek S.J., Drozdowicz D., Pajdo R., Mierzwa M.: Rola produktów cyklooksygenazy COX-1 i COX-2 oraz niesteroidowych leków przeciwzapalnych w mechanizmach obronnych błony śluzowej żoła̧dka. Probl. Ter. Monitorowanej, 2002, 13, supl. 1, 12-22.
61. Chłopicki S.: Wybiórcze inhibitory COX-2 - nowa klasa niesteroidowych leków przeciwzapalnych. Probl. Ter. Monitorowanej, 2002, 13, supl. 1, 3-11.
62. Konturek S.J., Pawlik W.: Physiology and pharmacology of prostaglandins. Dig. Dis. Sci., 1986, 31, suppl. 2, S6-S19.
63. Inauen W., Wyss P.A., Kayser S., Baumgarten A., Schurer-Maly C.C., Koezl H.R., Halter F.: Influence of prostaglandins, omeprazole and indomethacin on healing of experimental gastric ulcers in rat. Gastroenterology, 1998, 95, 636-641.
64. Bugajski J., Ga̧dek-Michalska A., Bugajski A.J.: Effect of cyclooxygenase inhibitors on the CRH-induced pituitary-adrenocortical activity during crowding stress. J. Physiol. Pharmacol., 2003, 54, 99-108.
65. Bugajski J., Ga̧dek-Michalska A., Bugajski A.J.: Effect of cyclooxygenase inhibitors on the vasopressin induced ACTH and corticosterone response during crowding stress. J. Physiol. Pharmacol., 2003, 54, 247-256.
66. Bugajski A.J., Thor P., Głód R., Ga̧dek-Michalska A., Bugajski J.: Influence of cyclooxygenase inhibitors on the central histaminergic stimulation of hypothalamic-pituitary-adrenal axis. J. Physiol. Pharmacol., 2003, 54, 643-652.
67. Warzecha Z., Dembiński A., Ceranowicz P., Konturek P.C., Niemiec J., Stachura J., Tomaszewska R., Konturek S.J.: The influence of sensory nerves and CGRP on the pancreatic regeneration after repeated episodes of acute pancreatitis in rats. J. Physiol. Pharmacol., 2000, 51, 449-461.
68. 2 accelerate mucosal recovery from stress-induced gastric lesions via inhibition of apoptosis. J. Physiol. (Paris), 2001, 95, 361-367.
69. Żbikowska H.M., Olas B.: Antioxidants with carcinostatin activity (resveratrol, vitamin E and selenium) in modulation of blood platelet adhesion. J. Physiol. Pharmacol., 2000, 51, 513-520.
70. Brzozowski T., Konturek P.C., Konturek S.J., Schuppan D., Drozdowicz D., Kwiecień S., Majka J., Nakamura T., Hahn E.G.: Effect of local application of growth factors on gastric ulcer healing and mucosal expression of cyclooxygenase-1 and -2. Digestion, 2001, 64, 15-29.
71. Brzozowski T., Konturek P.Ch., Konturek S.J., Pajdo R., Schuppan D., Drozdowicz D., Ptak A., Pawlik M., Nakamura T., Hahn E.G.: Involvement of cyclooxygenase (COX-2) products in acceleration of ulcer healing by gastrin and hepatocyte growth factor. J. Physiol. Pharmacol., 2000, 51, 751-773.
72. Konturek P.C., Hartwich A., Żuchowicz M., Łabza H., Pierzchalski P., Karczewska E., Bielański W., Hahn E.G., Konturek S.J.: Helicobacter pylori, gastrin and cyclooxygenase in gastric cancer. J. Physiol. Pharmacol., 2000, 51, 737-749.
73. Brzozowski T., Konturek P.C., Konturek S.J., Kwiecień S., Drozdowicz D., Bielański W., Pajdo R., Ptak A., Nikiforuk A., Pawlik W.W., Hahn E.G.: Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. Regul. Pept., 2004, 120, 39-51.
74. Konturek P.C., Brzozowski T., Kwiecień S., Drozdowicz D., Harsch I.A., Meixner H., Stachura J., Hahn E.G, Konturek S.J.: Effect of Helicobacter pylori on delay in ulcer healing induced by aspirin in rats. Eur. J. Pharmacol., 2002, 451, 191-202.
75. Zwolińska-Wcisło M., Brzozowski T., Kwiecień S., Drozdowicz D., Bogdał J., Budak A., Konturek S., Pawlik W.: Kolonizacja grzybicza przewodu pokarmowego w badaniach klinicznych i doświadczalnych. Przew. Lek., 2003, 9, 81-89.
76. Smith W.L., Langenbach R.: Why there are two cyclooxygenase isoenzymes. J. Clin. Invest., 2001, 107, 1491.
77. Peskar B.M.: Neural aspects of prostaglandin involvement in gastric mucosal defense. J. Physiol. Pharmacol., 2001, 52, 555-568.
78. Brzozowski T., Kwiecień S., Konturek P.Ch., Konturek S.J., Ptak A., Mitis-Musioł M., Duda A., Bielański W., Hahn E.G.: Comparison of nitric oxide-releasing NSAID and vitamin C with classic NSAID in healing of chronic gastric ulcers; involvement of reactive oxygen species. Med. Sci Monit., 2001, 7, 592-599.
79. Brzozowski T., Konturek P.Ch., Konturek S.J., Kwiecień S., Śliwowski Z., Pajdo R., Duda A., Ptak A., Hahn E.G.: Implications of reactive oxygen species and cytokines in gastroprotection against stress-induced gastric damage by nitric oxide releasing aspirin. Int. J. Colorectal Dis., 2003, 18, 320-329.
80. Kwiecień S., Brzozowski T., Konturek S.J.: Effects of reactive oxygen species action on gastric mucosa in various models of mucosal injury. J. Physiol. Pharmacol., 2002, 53, 39-50.
81. Takeuchi K., Suzuki K., Yamamoto H., Araki H., Mizoguchi H., Ukawa H.: Cyclooxygenase-2 selective and nitric oxide - releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses. J. Physiol. Pharmacol., 1998, 49, 501-513.
82. Konturek P.C., Kania J., Kukharsky V., Ocker S., Hahn E.G., Konturek S.J.: Influence of gastrin on the expression of cyclooxygenase-2, hepatocyte growth factor and apoptosis-related proteins in gastric epithelial cells. J. Physiol. Pharmacol., 2003, 54, 17-32.
83. Bartosz G.: Druga twarz tlenu. PWN, Warszawa, 2003.
84. Forman H.J., Thomas M.J.: Oxidant production and bactericidal activity of phagocytes. Annu. Rev. Physiol., 1986, 48, 669.
85. Parks D.A.: Oxygen radicals: mediators of gastrointestinal pathophysiology. Gut, 1989, 30, 293-298.
86. Murakami M., Asagoe K., Dekigai H., Kusaka S., Saita H., Kita T.: Products of neutrophil metabolism increase ammonia - induced gastric mucosal damage. Dig. Dis. Sci., 1995, 40, 268-273.
87. Suzuki M., Miura S., Suematsu M., Fukumura D., Suzuki H., Kai A., Tsuchiya M.: Helicobacter pylori elicits gastric mucosal cell damage associated with neutrophil - derived toxic oxidants. Eur. J. Gastroenterol. Hepatol., 1993, 5, suppl. 1, 35-39.
88. Guzik T.J., West N.F.J., Black E.: Vascular superoxide production by NAD(P)H oxidase; association with endothelial dysfunction and clinical risk factor. Circ. Res., 2000, 86, E85-E90.
89. Griendling K.K., Sorescu D., Ushio-Fukai M.: NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res., 2000, 86, 494-501.
90. Guzik T.J., Mussa S., Gastaldi D.: Mechanisms of increased vascular superoxide production in human diabetes mellitus; Role of NAD(P)H oxidase and endothelial nitric oxide. Circulation, 2002, 105, 1656-1662.
91. Bellavite P., Dri P., della Bianca V., Serra M.C.: The measurement of superoxide anion production by granulocytes in whole blood. A clinical test for the evaluation of phagocyte function and serum opsonic capacity. Eur. J. Clin. Invest., 1983, 13, 363-368.
92. 2 in vivo ESR technique. Free Radic. Res., 2003, 37, 757-766.
93. Kurzelewski M., Czarnowska E., Borȩsewicz A.: Superoxide- and nitric oxide-derived species mediate endothelial dysfunction, endothelial glycocalyx disruption and enhanced neutrophil adhesion in the post-ischemic guinea-pig heart. J. Physiol. Pharmacol., 2005, 56, 163-178.
94. Hildeman D.A., Mitchell T., Kappler J., Marrack P.: T cell apoptosis and reactive oxygen species. J. Clin. Invest., 2003, 111, 575-581.
95. Halliwell B.: How to characterize a biological antioxidant. Free Radical Res. Commun., 1990, 9, 1-32.
96. Cleveland J.L., Kastan M.B.: A radical approach to treatment. Nature, 2000, 407, 309-311.
97. Yasukawa K., Kasazaki K., Hyodo F., Utsumi H.: Non-invasive analysis of reactive oxygen species generated in rats with water immersion restraint-induced gastric lesions using in vivo electron spin resonance spectroscopy. Free Radic. Res. 2004, 38, 147-155.
98. Casini A., Ceni E., Salzano R., Biondi P., Parola M., Galli A., Foschi M., Caligiuri A., Pinzani M., Surrenti C.: Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells; role of nitric oxide. Hepatology, 1997, 25, 361-367.
99. Chamulirat W., Skrepnik N.V., Spitzer J.J.: Endotoxin-induced oxidative stress in the rat small intestine: role of nitric oxide. Shock, 1996, 5, 217-222.
100. Esterbauer H., Schaur R.J., Zollner H.: Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med., 1991, 11, 81-128.
101. Liu J., Yeo H.C., Doniger S.J., Ames B.N.: Assay of aldehydes from lipid peroxidation: gas chromatography-mass spectrometry compared to thiobarbituric acid. Anal. Biochem., 1997, 245, 161.
102. Banach M., Rysz J., Zasłonka J., Ostrowski S., Okoński P.: Kardioprotekcyjny wpływ podawania trimetazydyny u pacjentów poddanych rewaskularyzacji chirurgicznej serca. Przew. Lek., 2005, 4, 48-53.
103. Jain S., Thomas M., Kumar G.P., Laloraya M.: Programmed lipid peroxidation of biomembranes generating kinked phospholipids permitting local molecular mobility: a peroxide theory of fluidity management. Biochem. Biophys. Res. Commun., 1993, 195, 574-580.
104. Jain S.K.: Elevated malonyldialdehyde levels alterated membrane lipid asymmetry and hypercoagulability of erythrocytes from newborn infants. Biomed. Biochem. Acta, 1987, 46, S21-S25.
105. Kourie J.I.: Interaction of reactive oxygen species with ion transport mechanisms. Am. J. Physiol., 1998, 275, C1-C24.
106. Hoffmann T., Meyer R.J., Sorell M.F., Tuma D.J.: Reaction of acetaldehyde with proteins: formation of stable fluorescent adducts. Alcohol. Clin. Exp. Res., 1993, 17, 69-74.
107. Kikugawa K., Beppu M.: Involvement of lipid oxidation products in the formation of fluorescent and cross-linked proteins. Chem. Phys. Lipids, 1987, 44, 277-296.
108. Niemela O.: Aldehyde-protein adducts in the liver as a result of ethanol-induced oxidative stress. Front. Biosci., 1999, 4, D506-D513.
109. Konturek P.Ch., Duda A., Brzozowski T., Konturek S.J., Kwiecień S., Drozdowicz D., Pajdo R., Meixner H., Hahn E.G.: Activation of genes for superoxide dismutase, interleukin-1β, tumor necrosis factor-α and intercellular adhesion molecule-1 during healing of ischemia - reperfusion gastric injury. Scand. J. Gastroenterol., 2000, 35, 452-463.
110. Bełtowski J., Wójcicka G., Górny D., Marciniak A.: The effect of dietary-induced obesity on lipid peroxidation, antioxidant enzymes and total plasma antioxidant capacity. J. Physiol. Pharmacol., 2000, 51, 883-896.
111. Li X., Wang L.J., Tang N., Yue H., Huang Y., Lu J., Wang B.: Effects of isovolumetric hemodilution treatment and superoxide dismutase on ischemic reperfused hearts in rabbit. Clin. Hemorheol. Microcirc., 1998, 18, 157-163.
112. Keller J.N., Kindy M.S., Holtsberg F.W., St-Clair D.K., Yen H.C., Germeyer A., Steiner S.M., Bruce-Keller A.J., Hutchins J.B., Mattson M.P.: Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxydation and mitochondrial dysfunction. J. Neurosci., 1998, 18, 687-697.
113. Fisher C.L., Cabelli D.E., Tainer J.A., Hallewell R.A., Getzoff E.D.: The role of arginine 143 in the electrostatics and mechanism of Cu, Zn superoxide dismutase: computational and experimental evaluation by mutational analysis. Proteins, 1994, 19, 24-34.
114. Getzoff E.D., Tainer J.A., Weiner P.K., Kollman P.A., Richardson D.C.: Electrostatic recognition between superoxide and copper, zinc superoxide dismutase. Nature, 1983, 306, 287-290.
115. Amstad P., Moret R., Ceruti P.: Glutathione peroxidase compensates for the hypersensitivity of Cu,Zn- superoxide dismutase overproducers to oxidant stress. J. Biol. Chem., 1994, 269, 1606-1609.
116. Czeczot H., Ścibior D., Skrzycki M., Podsiad M., Porembska Z.: Glutathione level and activity of GSH-dependent enzymes in gastric carcinoma patients - a preliminary report. Gastroenterol. Pol., 2005, 12, 107-111.
117. Bartosz G.: Metabolizm glutationu. Post. Biochem.,1993, 39, 32-38.
118. Olas B., Wachowicz B., Bald E., Głowacki R.: The protective effects of resveratrol against changes in blood platelet thiols induced by platinum compounds. J. Physiol. Pharmacol., 2004, 55, 467-476.
119. Awasthi Y.C., Sharma R., Cheng J.Z., Yang Y., Sharma A., Singhal S.S., Awasthi S.: Role of 4-hydroxynonenal in stress-mediated apoptosis signaling. Mol. Aspects Med., 2003, 24, 219-230.
120. Alary J., Gueraud F., Cravedi J.P.: Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways. Mol. Aspects Med., 2003, 24, 177-187.
121. Winterbourn C.C.: Superoxide as an intracellular radical sink. Free Radic. Biol. Med., 1993, 14, 85-90.
122. Koppenol W.H.: A thermodynamic appraisal of the radical sink hypothesis. Free Radic. Biol. Med., 1993, 14, 91-94.
123. Brzozowski T., Zwolińska-Wcisło M., Konturek P.C., Kwiecień S., Drozdowicz D., Konturek S.J., Stachura J., Budak A., Bogdał J., Pawlik W.W., Hahn E.G.: Influence of gastric colonization with Candida albicans on ulcer healing in rats: Effect of ranitidine, aspirin and probiotic therapy. Scand. J. Gastroenterol., 2005, 40, 286-296.
124. Kwiecień S., Pawlik M.W., Brzozowska I., Śliwowski Z., Brzozowski T., Pawlik W.W., Kwiecień N., Konturek S.J.: Wpływ substancji naczyniorozszerzaja̧cych na peroksydacjȩ lipidów i mechanizmy antyoksydacyjne w błonie śluzowej żoła̧dka. Clin. Exp. Med. Lett., 2005, 46, 33-38.
125. Brzozowski T., Konturek P.C., Moran A.P., Kwiecień S., Pajdo R., Konturek S.J., Drozdowicz D., Ptak A., Pawlik W., Hahn E.G.: Enhanced resistance of gastric mucosa to damaging agents in the rat stomach adapted to Helicobacter pylori lipopolysaccharide. Digestion, 2003, 67, 195-208.
126. Konturek P.C., Brzozowski T., Konturek S.J., Kwiecień S., Pajdo R., Drozdowicz D., Stachura J., Karczewska E., Hahn E.G.: Functional and morphological aspects of Helicobacter pylori-induced gastric cancer in Mongolian gerbils. Eur. J. Gastroenterol. Hepatol., 2003, 15, 745-754.
127. Konturek P.C., Brzozowski T., Kania J., Kukharsky V., Bazela K., Kwiecie? S., Harsh I., Konturek S.J., Hahn E.G.: Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischemia/reperfusion in rat. Scand. J. Gastroenterol., 2003, 3, 468-476.